Skip to main content
SpringerLink
Log in

Development of Stereoselective Method for the Quantification of Stereoisomers and Geometrical Isomer of Pitavastatin Calcium by Enhanced Approach

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

A new, simple, selective, and robust normal-phase method for the accurate quantification of all the four stereoisomers and one geometrical isomer of pitavastatin calcium (PIT) in drug substances and drug products was developed. The method is capable of quantifying all the isomers in the presence of other related substances. Separation was achieved using immobilized amylose stationary phase (Chiralpak IA) with a mixture of n-heptane, 1-butanol, methanol, formic acid, and diethylamine. Multivariate analysis and statistical tools were used to develop this highly robust method in a short span of time. A central composite design was employed to study the main effects and interactions of the independent variables. The method exhibited consistent, high-quality recoveries [97.3 ± 1.7 to 99.3 ± 2.1 (mean ± RSD)] with a high precision for all the isomers. Linear regression analysis revealed an excellent correlation between peak responses and concentrations (r 2 values of 0.9990–0.9998) for the isomers. The method is sensitive enough to quantify any isomers above 0.02 % and detect any isomer above 0.006 % in PIT. Forced degradation studies proved that the method is specific for isomers. m/z values were determined for the major degradants and their possible structures were proposed on the basis of the known reactivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Stender S, Budinski D, Hounslow N (2013) Pitavastatin shows greater lipid lowering efficacy over 12 weeks than pravastatin in elderly patients with primary hypercholesterolemia or combined dyslipidaemia. Eur J Prev Cardiol 20:29–39

    Article  Google Scholar 

  2. Stender S, Budinski D, Hounslow N (2013) Pitavastatin demonstrates long-term efficacy, safety and tolerability in elderly patients with primary hypercholesterolaemia or combined (mixed) dyslipidaemia. Eur J Prev Cardiol 20:40–53

    Article  Google Scholar 

  3. Gumprecht J, Gosho M, Budinski D, Hounslow N (2011) Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20–40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia. Diabetes Obes Metab 13:1047–1055

    Article  CAS  Google Scholar 

  4. Eriksson M, Budinski D, Hounslow N (2011) Long-term efficacy of pitavastatin versus simvastatin. Adv Ther 28:799–810

    Article  CAS  Google Scholar 

  5. Ose L, Budinski D, Hounslow N, Arneson V (2010) Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia. Atherosclerosis 210:202–208

    Article  CAS  Google Scholar 

  6. FDA/Center for Drug Evaluation and Research (2009) Label Information—drugs at FDA, MD-20993. http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022363s010lbl.pdf. Accessed Oct 2012

  7. Patrizia G, Maria CP, Giuseppina G, Anna MM, Elena C, Simona P, Antonietta S, Chiara L, Maurizio B (2012) Pharmacological actions of statins: a critical appraisal in the management of cancer. Pharmacol Rev 64:102–146

    Article  Google Scholar 

  8. Pharma Book Syndicate (2009) Hyderabad, India. http://www.pharmabooksyndicate.com/issues/309.pdf. Accessed Mar 2009

  9. Ramakrishna N, Koteshwara M, Vishwottam K (2007) Chromatography-mass spectrometry methods for the quantification of statins in biological samples. J Pharm Biomed Anal 44:379–387

    Article  Google Scholar 

  10. Jianzhong ST, Xiao X, Jian L, Xingjiang H, Junchun C, Lihua W, Mingzhu H, Huili Z (2009) Determination of pitavastatin in human plasma by LC–MS–MS. Chromatographia 69:1041–1047

    Article  Google Scholar 

  11. Antony RG, Pannala RR, Nimmakayala S, Jadi S (2010) Degradation pathway for pitavastatin calcium by validated stability indicating UPLC method. Am J Anal Chem 1:83–90

    Article  Google Scholar 

  12. Satheesh NK, Baghyalakshmi J (2007) Determination and quantification of pitavastatin calcium in tablet dosage formulation by HPTLC method. Anal Lett 40:2625–2632

    Article  Google Scholar 

  13. Hiral JP, Bhanubhai NS, Natubhai JP, Bhavesh HP (2008) A simple and sensitive HPTLC method for quantitative analysis of pitavastatin calcium in tablets. J Planar Chromatogr 21:267–270

    Article  Google Scholar 

  14. Cheng X, Wang L, Yang G, Cheng J, Zhang Y (2010) Chiral separation of pitavastatin calcium enantiomers by capillary zone electrophoresis. Se Pu 28:1089–1093

    CAS  Google Scholar 

  15. Vishnu MM, Krishnaiah C, Kodithyala J, Katkam S, Mukkanti K, Ramesh K, Gautam S (2011) Enantioseparation of palonosetron hydrochloride and its related enantiomeric impurities by computer simulation and validation. Am J Anal Chem 2:437–446

    Article  Google Scholar 

  16. ICH (2012) Development and manufacture of drug substances Q11. ICH harmonised tripartite guideline. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q11/Q11_Step_4.pdf. Accessed 1 May 2012

  17. LCGC (2008) A strategy for developing HPLC methods for chiral drugs. http://www.chromatographyonline.com/lcgc/data/articlestandard/lcgc/122008/504160/article.pdf. Accessed Feb 2008

  18. Al-Othman Z, Ali I, Asim M, Khan TA (2012) Recent trends in chiral separations on immobilized polysaccharides CSPs. Comb Chem High Throughput Screen 15(4):339–346

    Article  CAS  Google Scholar 

  19. Irving WW, Rose MS (1987) Resolution of enantiomeric aromatic alcohols on a cellulose tribenzoate high-performance liquid chromatography chiral stationary phase: a proposed chiral recognition mechanism. J Chromatogr A 411:139–151

    Article  Google Scholar 

  20. Brian LH (2010) In: Alain B (ed) Chiral recognition in separation methods: mechanisms and applications. Springer, New York

    Google Scholar 

  21. Chiral Technologies Europe (2004) Instruction manual for Chiralpak-IA column. http://www.mz-at.de/pdf/Chiralpak_IA_Manual.pdf. Accessed April 2004

  22. Paul F, Mark H, Jennifer Y (2012) In: Wei Z, Berkeley C (eds) Green techniques for organic synthesis and medicinal chemistry. Wiley, West Sussex

    Google Scholar 

  23. Zhang T, Franco P, Nguyen D, Hamasaki R, Miyamoto S, Ohnishi A, Murakami T (2012) Complementary enantiorecognition patterns and specific method optimization aspects on immobilized polysaccharide-derived chiral stationary phases. J Chromatogr A 1269:178–188

    Article  CAS  Google Scholar 

  24. Toussaint B, Duchateau AL, Vanderwal S, Albert A, Hubert P, Crommen J (2000) Determination of the enantiomers of 3-tert-butylamino-1,2-propanediol by high-performance liquid chromatography coupled to evaporative light scattering detection. J Chromatogr A 890:239–249

    Article  CAS  Google Scholar 

  25. Tang Y (1996) Significance of mobile phase composition in enantioseparation of chiral drugs by HPLC on a cellulose-based chiral stationary phase. Chirality 8:136–142

    Article  CAS  Google Scholar 

  26. Parajo JC, Alonso JL, Lage MA, Vazquez D (1992) Empirical modeling of eucalyptus wood processing. Bioprocess Eng 8:129–136

    Article  CAS  Google Scholar 

  27. Suresh KR, Hariram B, Divya G, Srinivasu MK, Srinivas K, Sagyam RR (2012) Development of a RP-LC method for a diastereomeric drug valganciclovir hydrochloride by enhanced approach. J Pharm Biomed Anal 70:101–110

    Article  Google Scholar 

  28. Grobelny P, Viola G, Vedaldi D, Dallacqua F, Gliszczynska S A, Mielcarek J (2009) Photo stability of pitavastatin—a novel HMG-CoA reductase inhibitor. J Pharm Biomed Anal 50:597–601

    Article  CAS  Google Scholar 

  29. ICH (2005) Validation of analytical procedures: text and methodology Q2 (R1). ICH harmonised tripartite guideline. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf. Accessed Nov 2005

Download references

Acknowledgments

The authors wish to thank Dr. L. Kalyanaraman, Dr. Vyas, and the management of Dr. Reddy’s Laboratories for supporting this work.

Author information

Authors and Affiliations

  1. Integrated Product Development Organization, Dr. Reddy’s Laboratories Ltd, Bachupally, Hyderabad, 500072, India

    B. Hariram, R. Suresh Kumar, Dama Venugopala Rao, Rajeswar Reddy Sagyam & Katkam Srinivas

  2. Centre for Chemical Sciences and Technology, Jawaharlal Nehru Technological University, Kukatpally, Hyderabad, 500085, India

    B. Hariram & Anireddy Jayashree

Authors
  1. B. Hariram
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Suresh Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anireddy Jayashree
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dama Venugopala Rao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rajeswar Reddy Sagyam
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Katkam Srinivas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Hariram.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hariram, B., Kumar, R.S., Jayashree, A. et al. Development of Stereoselective Method for the Quantification of Stereoisomers and Geometrical Isomer of Pitavastatin Calcium by Enhanced Approach. Chromatographia 77, 901–912 (2014). https://doi.org/10.1007/s10337-014-2693-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-014-2693-x

Keywords

Search

Navigation